Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,215,661
+$17,396 QoQ
Shares Held
24,474
-3.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#1,459
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Keel Point, LLC holds $22,441,479 across 10 Drug Manufacturers - General names. JNJ ranks #1 (27.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
24,474 | $6,215,661 | |
| 2 | MRK |
Merck & Co., Inc.
|
36,633 | $4,707,340 | |
| 3 | LLY |
ELI LILLY & Co
|
3,650 | $4,377,919 | |
| 4 | ABBV |
AbbVie Inc.
|
11,997 | $3,018,925 | |
| 5 | NVS |
Novartis AG
|
6,229 | $976,208 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,068 | $892,971 | |
| 7 | AMGN |
Amgen Inc
|
2,204 | $798,112 | |
| 8 | AZN |
Astrazeneca PLC
|
3,042 | $576,824 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,215,661 | 24,474 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,198,265 | 25,357 | Shares | Sole | 2026-06-01 | |
| 2025-12-31 | $6,700,213 | 32,376 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,460,589 | 34,843 | Shares | Sole | 2025-12-16 | |
| 2025-06-30 | $5,349,152 | 35,019 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $5,743,702 | 34,634 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,505,780 | 31,156 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,413,290 | 33,403 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,844,327 | 33,144 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,959,256 | 31,350 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $4,352,356 | 27,768 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $4,392,928 | 28,205 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $4,817,128 | 29,103 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $4,260,950 | 27,490 | Shares | Sole | 2023-04-03 | |
| 2022-12-31 | $5,050,953 | 28,593 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $4,519,027 | 27,663 | Shares | Sole | 2022-10-05 | |
| 2022-06-30 | $4,889,157 | 27,543 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,077,107 | 28,647 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $7,683,266 | 44,913 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $7,066,594 | 43,756 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $6,939,013 | 42,121 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $6,592,571 | 40,113 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,237,598 | 39,634 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $5,307,572 | 35,650 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $1,906,942 | 13,560 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,829,132 | 13,949 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||